Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Amino-acid disorders including phenylketonuria and MSUD — formative SAQs

Formative SAQs on recognising the inherited amino-acid disorders (PKU, MSUD, tyrosinaemia type I, homocystinuria) on their metabolite and clinical signatures, delivering the acute 'switch off catabolism, clear the toxin' protocol for an MSUD crisis, and locking in long-term diet, cofactor and enzyme-substitution therapy with maternal PKU counselling.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Amino-acid disorders including phenylketonuria and MSUD

SAQ 1 (10 marks)

A term male neonate is well at birth and on breast and formula feeds. At 72 hours of age he becomes lethargic, feeds poorly, vomits, and is found with opisthotonic posturing and intermittent dystonia. The nursing staff note a sweet, caramel-like smell to his urine. A blood gas shows a high anion-gap metabolic acidosis with ketosis; the ammonia is normal. [7] [8]

a) Explain why this picture of a well neonate deteriorating 48 to 120 hours into feeds with ketoacidosis and an odour is classic for maple syrup urine disease, and name the single most specific confirmatory metabolite. (3 marks) [7]

b) Outline the acute management, naming the four moves of the shared metabolic protocol and the rationale for supplementing isoleucine and valine while restricting leucine. (4 marks) [7] [8]

c) Describe the role of extracorporeal removal, including the leucine threshold or trajectory that would trigger it, and explain why outcome tracks time on the toxic metabolite. [7] (3 marks) [7]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet, 2010.PMID 20971365
  2. [2]van Wegberg AMJ, MacDonald A, Ahring K, et al. European guidelines on diagnosis and treatment of phenylketonuria: First revision. Mol Genet Metab, 2025.PMID 40378670
  3. [7]Strauss KA, Puffenberger EG, Carson VJ Maple Syrup Urine Disease. GeneReviews, 1993.PMID 20301495
  4. [8]Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab, 2014.PMID 24881969
  5. [10]Ficicioglu C Tyrosinemia Type I. GeneReviews, 1993.PMID 20301688
  6. [11]Sacharow SJ, Levy HL Homocystinuria due to Cystathionine Beta-Synthase Deficiency. GeneReviews, 1993.PMID 20301697
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute metabolic decompensation: recognition and stabilisationgenetics-dysmorphology-and-metabolismNextChromosomal microarray, exome and genome sequencing — formative SAQsgenetics-dysmorphology-and-metabolism